ATG1

ATG1 (ULK1) Gene — Autophagy Initiation Kinase

Introduction

```mermaid
flowchart TD
classDef gene fill:#0a1f0a,stroke:#4caf50
classDef protein fill:#0a1929,stroke:#2196f3
classDef disease fill:#2d0f0f,stroke:#e91e63
classDef pathway fill:#3e2200,stroke:#ff9800
classDef mechanism fill:#1a0a1f,stroke:#9c27b0
classDef therapeutic fill:#e0f2f1,stroke:#009688
ATG1["ATG1"] -->|"implicated_in"| neurodegeneration["neurodegeneration"]
ATG1["ATG1"] -->|"associated_with"| ULK2["ULK2"]
ATG1["ATG1"] ==>|"activates"| ULK1["ULK1"]
ATG1["ATG1"] ==>|"activates"| Als["Als"]
ATG1["ATG1"] ==>|"activates"| Mitophagy["Mitophagy"]
ATG1["ATG1"] -->|"associated_with"| Autophagy["Autophagy"]
ATG1["ATG1"] ==>|"activates"| P62["P62"]
ATG1["ATG1"] -->|"associated_with"| AMPK["AMPK"]
ATG1["ATG1"] -->|"interacts_with"| PI3K["PI3K"]
ATG1["ATG1"] -->|"interacts_with"| ATG["ATG"]
ATG1["ATG1"] -->|"interacts_with"| ATG13["ATG13"]
ATG1["ATG1"] -->|"interacts_with"| AUTOPHAGY["AUTOPHAGY"]
ATG1["ATG1"] -->|"interacts_with"| ATG5["ATG5"]
ATG1["ATG1"] ==>|"activates"| Ms["Ms"]
ATG1["ATG1"] -->|"interacts_with"| Autophagy["Autophagy"]
ATG1["ATG1"] -->|"interacts_with"| Pi3K["Pi3K"]
ATG1["ATG1"] ==>|"activates"| MITOPHAGY["MITOPHAGY"]
ATG1["ATG1"] -->|"associated_with"| AUTOPHAGY["AUTOPHAGY"]
ATG1["ATG1"] ==>|"activates"| ALS["ALS"]
ATG1["ATG1"] -->|"expressed_in"| T_Cell["T Cell"]
ATG1["ATG1"] -->|"implicated_in"| SCA3["SCA3"]
ATG1["ATG1"] -->|"implicated_in"| RAB7["RAB7"]
ATG1["ATG1"] -->|"regu

ATG1 (ULK1) Gene — Autophagy Initiation Kinase

Introduction

Atg1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@egan2011]
<table> [@wang2018]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">ATG1 / ULK1</th></tr> [@jiang2021]
<tr><td><strong>Gene Symbol</strong></td><td>ATG1 (ULK1 in mammals)</td></tr> [@wu2020]
<tr><td><strong>Full Name</strong></td><td>Unc-51 Like Autophagy Activating Kinase 1</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>12q13.12</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[54973](https://www.ncbi.nlm.nih.gov/gene/54973)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y4P5](https://www.uniprot.org/uniprot/Q9Y4P5)</td></tr>
<tr><td><strong>Protein Type</strong></td><td>Serine/Threonine Kinase</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~105 kDa</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">59 edges</a></td>
</tr>
</table>
</div>

Overview

ATG1 (known as ULK1 in mammals) is the founding member of the ULK kinase complex and serves as the master initiator of [autophagy](/entities/autophagy). This serine/threonine kinase coordinates the recruitment and activation of the entire autophagy machinery in response to cellular stress, nutrient deprivation, and energy depletion. ULK1 is evolutionarily conserved from yeast (ATG1) to humans and is essential for autophagosome formation.

Function and Mechanism

ULK Kinase Complex

ULK1 forms a core complex with ATG13, FIP200, and ATG101 (also known as RB1CC1). This ULK1-ATG13-FIP200-ATG101 complex is the primary sensor of nutrient and energy status in cells:

• ULK1: Catalytic serine/threonine kinase that initiates autophagy signaling
• ATG13: Regulatory subunit that enhances ULK1 activity and serves as a scaffold
• FIP200: Scaffold protein that recruits downstream effectors
• ATG101: Stabilizing subunit that protects ATG13 from degradation

Autophagy Initiation

Upon starvation or [mTOR](/mechanisms/mtor-signaling-pathway) inhibition, ULK1 phosphorylates multiple downstream targets:

Energy Sensing

ULK1 is activated by AMP-activated protein kinase (AMPK) when cellular energy is low:

• AMPK phosphorylates ULK1 at multiple serine residues (Ser317, Ser555, Ser777)
• This activates ULK1 to initiate autophagy and restore energy homeostasis

Role in Neurodegenerative Diseases

Alzheimer's Disease

In AD, ULK1-mediated autophagy is dysregulated at multiple levels:

• [Amyloid-beta](/proteins/amyloid-beta) impact: Aβ accumulation suppresses ULK1 activity through mTOR hyperactivation, impairing autophagic clearance
• [Tau](/proteins/tau) pathology: ULK1 phosphorylates tau at multiple sites; dysregulated ULK1 may contribute to abnormal tau aggregation
• Autophagy-lysosomal dysfunction: ULK1-dependent autophagosome formation is impaired in AD [neurons](/entities/neurons)
• Therapeutic targeting: Small molecule ULK1 activators (e.g., LTB4 agonists) promote Aβ clearance in preclinical models

Parkinson's Disease

ULK1 plays critical roles in PD pathogenesis:

• Mitophagy regulation: ULK1 phosphorylates PINK1 and Parkin to coordinate mitophagy of damaged mitochondria
• [Alpha-synuclein](/proteins/alpha-synuclein) clearance: ULK1 activity is required for the autophagic degradation of alpha-synuclein aggregates
• [LRRK2](/entities/lrrk2) interaction: ULK1 phosphorylates LRRK2 at Ser910/Ser935, regulating its subcellular localization
• Genetic susceptibility: ULK1 polymorphisms are associated with sporadic PD risk

Amyotrophic Lateral Sclerosis (ALS)

• [TDP-43](/mechanisms/tdp-43-proteinopathy) aggregates: ULK1-mediated mitophagy is impaired in TDP-43 ALS models
• [C9orf72](/entities/c9orf72): The ULK1 complex interacts with C9orf72 in regulating autophagy
• FUS mutations: ULK1 activity is reduced in FUS-ALS, contributing to defective autophagy

Other Neurodegenerative Conditions

• Huntington's Disease: ULK1 activity is beneficial for clearing mutant [huntingtin protein](/proteins/huntingtin) aggregates
• Prion Diseases: ULK1-mediated autophagy is suppressed in prion-infected neurons
• Multiple System Atrophy: ULK1 dysregulation contributes to oligodendrocyte degeneration

Therapeutic Implications

| Approach | Mechanism | Status |
|----------|-----------|--------|
| ULK1 agonists | Activate autophagy to clear protein aggregates | Preclinical |
| mTOR inhibitors | Indirectly activate ULK1 by relieving inhibition | Approved (rapamycin) |
| AMPK activators | Directly phosphorylate and activate ULK1 | Research |
| Gene therapy | Overexpress ULK1 in target neurons | Preclinical |

Interactions

• Positive regulators: AMPK, mTOR (inhibition releases ULK1), p53
• Negative regulators: mTORC1, Akt
• Downstream effectors: Beclin-1, ATG14L, ATG13, LC3, ATG9
• Disease proteins: α-synuclein, tau, TDP-43, mutant huntingtin

Background

The study of Atg1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Cross-References

• [ULK1 Protein](/proteins/ulk1-protein)
• [Autophagy in Neurodegeneration](/mechanisms/autophagy-lysosome-neurodegeneration)mechanisms/autophagy-lysosomal-pathway)
• [Mitophagy in Parkinson's Disease](/mechanisms/mitophagy-parkinsons-disease)
• [AMPK Signaling](/mechanisms/ampk-signaling-neurodegeneration)

External Links

• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/) - Gene database
• [UniProt](https://www.uniprot.org/) - Protein database

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ATG1 discovered through SciDEX knowledge graph analysis: